416 completed, 113 unknown, 72 recruiting, 56 active not recruiting. 207 Not applicable, 149 Phase 3, 139 Phase 2, 52 Phase 1, 47 Phase 4.
Follow Papillomavirus Infections: new trials by email Literature Review of Papillomavirus Infections trials Research Report on Papillomavirus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of SR-T100 Gel in Common Warts (CW) Patients Vehicle gel, SR-T100 gel with 1.0% of SM, SR-T100 gel with 2.3% of SM - Common Wart | Phase 2 | Suspended | G&E Herbal Biotechnology Co., LTD | 102 | 2030-09-01 | 2023-09-14 |
| Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial Protect Me 4 Application + External Quality Improvement Support, Protect Me 4 Application Alone - Human Papillomavirus (HPV) Vaccines | Not applicable | Not yet recruiting | University of Florida | 1296 | 2027-09-15 | 2026-09-14 |
| Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With Human Papillomavirus (HPV) Papilozumib vaginal gel, Papilozumib oral supplement - Human Papillomavirus Infection, Human Papillomavirus Infections | Not applicable | Not yet recruiting | Hifas da Terra S.L. | 81 | 2027-07-01 | 2026-10-05 |
| Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men Cytology Specimen Collection Procedure, High Resolution Anoscopy with Biopsy, Laboratory Biomarker Analysis - HIV Infection, Human Papillomavirus Infection | Withdrawn | AIDS Malignancy Consortium | 2027-04-30 | 2025-06-06 | ||
| Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs ATRN-119, Stereotactic Body Radiation Therapy (SBRT) - HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma | Phase 1 / Phase 2 | Not yet recruiting | Abramson Cancer Center at Penn Medicine | 35 | 2027-01-31 | 2026-10-27 |
| Zopapogene Imadenovec for the Treatment of Recurrent Respiratory Papillomatosis in Children Zopapogene imadenovec-drba - Recurrent Respiratory Papillomatosis (RRP), Juvenile-onset Recurrent Respiratory Papillomatosis | Phase 3 | Not yet recruiting | Precigen, Inc | 15 | 2026-12-31 | 2026-10-28 |
| Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) PRGN-2012, Bevacizumab - Respiratory Recurrent Papillomatosis (RRP), Human Papillomavirus (HPV) | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 50 | 2026-11-04 | 2026-10-30 |
| Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Busulfan, Palifermin, Plerixafor - WHIM, Warts | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2026-10-21 | 2026-10-27 |
| A Clinical Study of V503 in Chinese Females Who Have Previously Received a Bivalent Human Papillomavirus (HPV) Vaccine (V503-108) V503, Placebo - Papillomavirus Infections | Phase 3 | Recruiting | Merck Sharp & Dohme LLC | 930 | 2026-10-10 | 2026-10-22 |
| Intralesional Acyclovir Versus Intralesional Zinc Sulphate in the Treatment of Plantar Warts Intralesional Acyclovir, Intralesional Zinc Sulphate - Warts, Plantar Warts | Phase 3 | Not yet recruiting | Assiut University | 76 | 2026-10-01 | 2026-09-29 |
| Epidemiology of Anal Human Papillomavirus Carriage in Female Solid Organ Transplant Recipients With More Than 10 Years of Immunosuppression Anal Self-Sampling for High-Risk HPV Detection - Human Papillomavirus Infection, Anal HPV Infection | Not applicable | Not yet recruiting | University Hospital, Montpellier | 190 | 2026-10-01 | 2026-10-05 |
| Immunogenicity and Safety of HPV-4 Vaccine With or Without Td Vaccine in Children Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine, Tetanus-Diphtheria booster - Human Papillomavirus (HPV) Infection | Phase 3 | Not yet recruiting | PT Bio Farma | 266 | 2026-10-01 | 2026-09-17 |
| Clinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) Vaccine 10vHPV, Gardasil9 - Human Papillomavirus Infection | Phase 1 / Phase 2 | Not yet recruiting | Serum Institute of India Pvt. Ltd. | 72 | 2026-10-01 | 2026-10-22 |
| Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5) VP-102 - Common Warts, Common Warts (Verruca Vulgaris) | Phase 2 | Not yet recruiting | Verrica Pharmaceuticals Inc. | 30 | 2026-10-01 | 2026-10-20 |
| The Effect of Health Belief Model-Based HPV Infection and Vaccination Education on University Students' Knowledge and Health Beliefs Educational intervention HPV - Health Belief Model, Nursing Students | Not applicable | Not yet recruiting | Mersin University | 67 | 2026-10-01 | 2026-10-28 |
| Comparing Digital and Collaborative Gamified Reinforcement Strategies for HPV Literacy and Retention Among Nursing Students Escape Room-Based Gamified Reinforcement, Gimkit-Based Gamified Reinforcement - Health Literacy, Human Papillomavirus (HPV) Infection | Not applicable | Not yet recruiting | Aydin Adnan Menderes University | 64 | 2026-09-21 | 2026-07-02 |
| Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women Living With HIV Model 1- Screening in Clinic Only, Model 2 - Screening in Clinic and Community - Cervix Cancer, HIV Infections | Not applicable | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 17734 | 2026-09-01 | 2026-09-02 |
| Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya 5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 140 | 2026-09-01 | 2026-08-27 |
| A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs at Minimal Risk and Primary Site Disease (SAVED) Dose de-escalation to contralateral neck., Dose de-escalation to gross disease to contralateral neck, Dose de-escalation to gross disease - Head and Neck Cancer, Head and Neck Squamous Cell Cancer | Phase 2 | Not yet recruiting | University of Maryland, Baltimore | 132 | 2026-09-01 | 2026-08-14 |
| Safety and Immunogenicity of HPV Vaccine in HIV-infected HPV vaccination - HIV-infected Individuals | Phase 1 / Phase 2 | Not yet recruiting | Beijing 302 Hospital | 80 | 2026-09-01 | 2026-09-01 |
Showing 20 of 752. Sign in to see all of them.
Uterine Cervical Neoplasms (191) · Warts (121) · Condylomata Acuminata (112) · Uterine Cervical Dysplasia (59) · HIV Infections (42) · Anus Neoplasms (31) · Vulvar Neoplasms (25) · Squamous Intraepithelial Lesions (24) · Vaginal Neoplasms (24) · Infections (22) · Oropharyngeal Neoplasms (19) · Squamous Cell Carcinoma of Head and Neck (18) · Neoplasms (17) · Precancerous Conditions (15)
DNA Virus Infections (745) · Tumor Virus Infections (745) · Virus Diseases (739) · Infections (730) · Pathological Conditions, Signs and Symptoms (646) · Communicable Diseases (644) · Urogenital Diseases (644) · Genital Diseases (643) · Pathologic Processes (643) · Disease Attributes (642) · Sexually Transmitted Diseases, Viral (641) · Sexually Transmitted Diseases (633) · Neoplasms (277) · Neoplasms by Site (240) · Female Urogenital Diseases and Pregnancy Complications (234)
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 (45) · human papillomavirus vaccine, L1 type 16, 18 (43) · Papillomavirus Vaccines (26) · Cryotherapy (15) · Human Papillomavirus Recombinant Vaccine nonavalent (14) · Vaccines (14) · Vaccines, Synthetic (14) · Blood Specimen Collection (10) · Colposcopy (9) · Data Collection (9) · Human Papillomavirus DNA Tests (8) · Cisplatin (7) · Imiquimod (7) · Radiotherapy, Intensity-Modulated (7) · Specimen Handling (7)
GlaxoSmithKline (71) · Merck Sharp & Dohme LLC (50) · National Cancer Institute (NCI) (20) · Assiut University (13) · Shanghai Bovax Biotechnology Co., Ltd. (13) · AIDS Malignancy Consortium (8) · Graceway Pharmaceuticals, LLC (8) · University of Washington (8) · Duke University (7) · Fujian Maternity and Child Health Hospital (7) · Xiamen University (7) · Aclaris Therapeutics, Inc. (6) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · Shanghai Zerun Biotechnology Co.,Ltd (6) · University Hospital, Geneva (6)
United States (220) · China (86) · France (32) · Canada (28) · Italy (23) · Germany (21) · Spain (21) · Belgium (19) · Taiwan (18) · Turkey (Türkiye) (18) · Egypt (17) · United Kingdom (16) · Australia (15) · Thailand (15) · Brazil (12)
Joel Palefsky, MD (5) · Jun Zhang, Master (5) · Jun Zhang, master (4) · Scott M Norberg, D.O. (4) · Ting Huang (4) · Vikrant V Sahasrabuddhe (4) · Yongjiang Liu, Bachelor (4) · Deanna Kepka, PhD, MPH (3) · Lameck Chinula, MD (3) · Lei Li, M.D. (3) · Pengming Sun (3) · Rachel L Winer, PhD, MPH (3)
PMID 41276263, PMID 27422279, PMID 19935017, PMID 32184277, PMID 31824976, PMID 19236277, PMID 19236279, PMID 24731816, PMID 25424785, PMID 25424918, PMID 29074187, PMID 29211620, PMID 30982556, PMID 33857679, PMID 35149535, PMID 41166720, PMID 15897380, PMID 17628649, PMID 18515521, PMID 19586656, PMID 20949623, PMID 21471141, PMID 22265115, PMID 22454089, PMID 23066159, PMID 23299013, PMID 23336207, PMID 23632723, PMID 25057165, PMID 25273231, PMID 25424783, PMID 27566633, PMID 29214505, PMID 29269325, PMID 29767739, PMID 29995724, PMID 31464859, PMID 32078808, PMID 32827835, PMID 33326342, PMID 33538338, PMID 34939897, PMID 10693114, PMID 10782451, PMID 11238198, PMID 11927495, PMID 12807939, PMID 13519856, PMID 14682443, PMID 15153912
U01CA121947 (7), 2004 (5), 2009 (3), 2016 (3), 2017 (3), 2018 (3), R01CA279973 (3), 2005 (2), 2008 (2), 2023 (2), U01IP001073 (2), U24CA275417 (2), U54CA242639 (2), UG1CA275403 (2), UM1CA121947 (2)